ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,859Medicare Part D Prescriptions Filled, Including Refills

Rank: 412 out of 1558

$558K Total Retail Price of All Prescriptions

Rank: 500 out of 1558

837 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in North Carolina
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 837 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 463 448 121 1 2
METFORMIN HCL 426 364 98 2 8
LEVOTHYROXINE SODIUM 399 366 86 3 4
LISINOPRIL 375 336 90 4 5
OMEPRAZOLE 375 338 85 4 3
AMLODIPINE BESYLATE 334 307 91 6 1
METOPROLOL TARTRATE 249 226 64 7 11
METOPROLOL SUCCINATE 233 228* 45 8 13
LORAZEPAM 220 208 53 B 9 31
ATORVASTATIN CALCIUM 217 199 51 10 6
FUROSEMIDE 198 162 56 11 7
SERTRALINE HCL 181 157 43 12 24
LOVASTATIN 168 132 39 13 45
CLOPIDOGREL 162 157* 40 14 19
RAMIPRIL 155 138 33 15 74
TRAMADOL HCL 146 128 48 16 21
LOSARTAN POTASSIUM 140 135* 42 17 14
ATENOLOL 133 128* 34 18 20
ALENDRONATE SODIUM 121 121 39 19 42
HYDROCHLOROTHIAZIDE 121 110 35 19 10
GABAPENTIN 121 91 32 19 15
ALPRAZOLAM 118 84 34 B 22 17
GEMFIBROZIL 118 113* 22 22 128
PANTOPRAZOLE SODIUM 110 99 25 24 28
FLUTICASONE PROPIONATE 109 97 39 25 30
PRAVASTATIN SODIUM 102 89 21 26 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 88 23 27 32
TAMSULOSIN HCL 98 93* 21 28 34
CARVEDILOL 97 92* 21 29 25
POTASSIUM CHLORIDE 97 76 30 29 16
NEXIUM 94 57 20 31 27
LOSARTAN-HYDROCHLOROTHIAZIDE 94 89* 19 31 36
BENAZEPRIL HCL 89 74 22 33 60
CRESTOR 78 73* 18 34 23
DIOVAN 77 72* 18 35 44
CITALOPRAM HBR 76 71* 23 36 26
KLOR-CON M20 75 62 15 37 56
CHLORTHALIDONE 73 68* 21 38 102
SPIRONOLACTONE 72 56 20 39 61
JANUVIA 72 49 15 39 75
PROAIR HFA 71 66* 33 41 52
DONEPEZIL HCL 69 69 26 42 35
HYDROCODONE-ACETAMINOPHEN 68 51 22 S3 43 9
OXYBUTYNIN CHLORIDE 65 60* 12 44 172
GLIPIZIDE XL 63 51 14 45 90
BOOSTRIX TDAP 62 57* 61 46 308
SPIRIVA 60 55* 15 47 57
ZETIA 58 <11 <11 48 64
ISOSORBIDE MONONITRATE ER 55 55 13 49 53
MONTELUKAST SODIUM 54 41 15 50 48
ESCITALOPRAM OXALATE 53 48* 15 51 51
LABETALOL HCL 52 <11 <11 52 147
DILTIAZEM 24HR CD 52 47* 11 52 84
ALLOPURINOL 52 52 16 52 33
MIRTAZAPINE 52 52 12 52 58
ADVAIR DISKUS 52 47* 12 52 54
NAMENDA 50 50 13 57 43
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 7, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.